Personalized Selection of Hyperangulated vs. Macintosh Videolaryngoscope Blades (HAVL)

January 26, 2026 updated by: Seoul National University Hospital

Personalized Selection of Hyperangulated vs. Macintosh Videolaryngoscope Blades: Randomized Controlled Trial and Development of an Integrated Predictive Algorithm

This study aims to determine whether hyperangulated blades have a higher intubation success rate than Macintosh blades in patients undergoing general anesthesia, and to identify patient subgroups in which hyperangulated blades are particularly advantageous for tracheal intubation.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

Randomized controlled trial

This study was designed as a randomized controlled trial. A total of 524 patients were randomly allocated in a 1:1 ratio to either the hyperangulated blade group (H group) or the Macintosh blade group (M group).

The primary endpoint was first-attempt intubation success. The secondary endpoints included the overall tracheal intubation success rate, the number of intubation attempts, time for the tracheal tube to pass through the vocal cords (T5), time to ventilation (T6), and the use of adjunctive airway maneuvers (e.g., external laryngeal manipulation [ELM]).

Between-group comparisons were performed according to the characteristics of each endpoint. Categorical variables were analyzed using the χ² test or Fisher's exact test, as appropriate, and results were presented as risk ratios (RRs) with 95% confidence intervals (CIs). Continuous variables were assessed for normality using the Shapiro-Wilk test. Normally distributed variables were compared using the independent-samples t-test, whereas non-normally distributed variables were analyzed using the Mann-Whitney U test. Results were reported as mean or median differences with 95% CIs.

All study participants experienced both videolaryngoscope blades. However, actual tracheal intubation was performed only with the second blade, while the first blade was used solely for assessment of glottic view and approach times. To minimize learning-related order effects, each attempt was performed by a different investigator, and each investigator was restricted to using only the blade assigned to them. In addition, within-patient comparisons of POGO scores, approach times, and visualization difficulty between the first and second blades were conducted to analyze blade-specific visualization characteristics. If significant differences were observed, potential order effects were further evaluated during the analysis.

Within-patient comparison (paired evaluation)

Before actual tracheal intubation, glottic visualization up to just before the vocal cords was assessed using both blades in all participants. The order of blade use was balanced according to randomization: patients in the M group underwent visualization assessment in the H→M sequence followed by intubation with the Macintosh blade, whereas patients in the H group underwent visualization assessment in the M→H sequence followed by intubation with the hyperangulated blade. Accordingly, within-patient comparisons were conducted using visualization data obtained in the predefined sequence for each group, thereby minimizing order effects.

The evaluated parameters included:

(i) time to obtain a laryngeal view (T1/T3), (ii) time for the tracheal tube tip to reach the vocal cords (T2/T4), (iii) VIDIAC score, (iv) percentage of glottic opening (POGO) score, (v) operator-reported subjective difficulty score, and (vi) complications (e.g., SpO₂ < 90%, dental or soft-tissue injury).

Differences in continuous paired outcomes between the hyperangulated and Macintosh blades were analyzed using the paired t-test or Wilcoxon signed-rank test, as appropriate. When classifying each outcome according to which blade was superior (hyperangulated-favored, Macintosh-favored, or equivalent), McNemar's test was used for binary classifications and the Stuart-Maxwell test for three-category classifications.

Machine learning-based exploratory analysis

Finally, data obtained from the randomized controlled trial and paired analyses were further leveraged to explore, in an exploratory manner, which blade may be more advantageous under specific anatomical and demographic conditions. Outcomes that demonstrated between-group differences in the primary or secondary analyses were selected as target variables. All covariates were included as input features, and an XGBoost-based ensemble tree model was trained.

Model performance was evaluated using the area under the receiver operating characteristic curve (AUROC) with 95% CIs for binary outcomes and root mean squared error (RMSE) and mean absolute error (MAE) for continuous outcomes. SHapley Additive exPlanations (SHAP) analysis was performed to visualize feature importance and interaction patterns, and decision curve analysis (DCA) was used to assess the clinical net benefit of the predictive models.

Study Type

Interventional

Enrollment (Estimated)

524

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adult patients aged ≥ 19 years undergoing surgery under general anesthesia.

Exclusion Criteria:

  • Patients who did not provide informed consent
  • Patients with severely loose or unstable teeth
  • Patients with cervical spine disease
  • Patients with American Society of Anesthesiologists (ASA) physical status class IV or higher
  • Pregnant women
  • Patients with head and neck cancer
  • Patients who had previous radiotherapy for head and neck cancer
  • Patients deemed unsuitable for study participation at the investigator's discretion

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Macintosh group
tracheal intubation was performed using a standard Macintosh-type videolaryngoscope blade
tracheal intubation was performed using a standard Macintosh-type videolaryngoscope blade
Experimental: Hyperangulated group
tracheal intubation was performed using a hyperangulated videolaryngoscope blade
tracheal intubation was performed using a hyperangulated videolaryngoscope blade

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
first attempt success rate
Time Frame: At the time of tracheal intubation (up to 10 min)
successful placement of the tracheal tube into the airway on the first attempt within 60 seconds, without the need for assistance from another operator or the use of adjunctive airway maneuvers.
At the time of tracheal intubation (up to 10 min)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Preoperative airway assessment included the modified Mallampati classification
Time Frame: before intubation (up to 10 min)
Class I: soft palate, fauces, pillars, and uvula visible; Class II: soft palate, fauces, and uvula visible; Class III: soft palate and base of the uvula visible; Class IV: soft palate not visible
before intubation (up to 10 min)
overall tracheal intubation success rate
Time Frame: At the time of tracheal intubation (up to 10 min)
overall tracheal intubation success rate
At the time of tracheal intubation (up to 10 min)
the number of attempts required to achieve successful intubation
Time Frame: At the time of tracheal intubation (up to 10 min)
the number of attempts required to achieve successful intubation
At the time of tracheal intubation (up to 10 min)
the use of adjunctive airway maneuver
Time Frame: At the time of tracheal intubation (up to 10 min)
the use of adjunctive airway maneuvers, such as external laryngeal manipulation (ELM)
At the time of tracheal intubation (up to 10 min)
time to obtain a laryngeal view with the first blade
Time Frame: At the time of tracheal intubation (up to 10 min)
T1: from insertion of the laryngoscope to visualization of the glottis
At the time of tracheal intubation (up to 10 min)
time for the tracheal tube to reach the vocal cords with the first blade
Time Frame: At the time of tracheal intubation (up to 10 min)
T2: from laryngoscope insertion to advancement of the tube to just before the vocal cords
At the time of tracheal intubation (up to 10 min)
time to obtain a laryngeal view with the second blade
Time Frame: At the time of tracheal intubation (up to 10 min)
T3: from laryngoscope insertion to visualization of the glottis
At the time of tracheal intubation (up to 10 min)
time for the tracheal tube to reach the vocal cords with the second blade
Time Frame: At the time of tracheal intubation (up to 10 min)
T4: from laryngoscope insertion to advancement of the tube to just before the vocal cords
At the time of tracheal intubation (up to 10 min)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

January 31, 2026

Primary Completion (Estimated)

December 31, 2026

Study Completion (Estimated)

December 31, 2027

Study Registration Dates

First Submitted

January 4, 2026

First Submitted That Met QC Criteria

January 21, 2026

First Posted (Actual)

January 27, 2026

Study Record Updates

Last Update Posted (Actual)

January 28, 2026

Last Update Submitted That Met QC Criteria

January 26, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2510-078-1683

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Airway Assessment

Clinical Trials on Macintosh group

Subscribe